Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.
Visiongain’ has launched a new pharma report Global Translational Regenerative Medicine Market Prospects 2018-2028: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies. Regenerative medicine has been undergoing a period of sustained innovation over the last two decades. Tissue engineering and stem cell research in particular have seen a level of interest which it hasn’t received ...

Indian Pharmaceutical Market Forecast 2018-2028

Indian Pharmaceutical Market Forecast 2018-2028
This report examines the current and future trends in the Indian pharmaceutical market. India has the second largest population in the world and with high levels of acute and chronic disease, it is already the third largest pharmaceutical market in the world by volume. The Indian market is characterised by extreme levels of generic penetration ...

Smart Pill Market World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World

Smart Pill Market World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World
LONDON, UK. 10th November 2017: Visiongain has launched a new pharma report Smart Pill Market World Market Forecast 2017-2027: See Prospects for Capsule Endoscopy, Drug Delivery and Patient Monitoring in North America, South America, Europe, Asia-Pacific and the Rest of the World. Smart Pill technology is a revolutionary technological innovation that has bridged the gap ...

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs
LONDON, UK. October 2017: Visiongain has launched a new pharma report Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs. The Latin American pharmaceutical market accounts for 8% of the global pharmaceutical industry, and is one of its fastest growing markets. Macroeconomic conditions ...

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others
Visiongain’ has launched a new pharma report Anti- Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others The potential of the OTC pharmaceutical market remains significant and it is a growing segment in the largely stagnant overall pharmaceutical market. In the face of looming patent ...

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs

Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs
LONDON, UK June 2017: Visiongain’s new report Global Ophthalmic Drugs Market Forecast 2017-2027: Dry Eye, Glaucoma Drugs, Retinal Disorders Drugs and Allergic, Inflammatory & Infective Drugs indicates that the global ophthalmic drugs market will see $28.1bn in spending in 2021. The global ophthalmic drugs market is expected to grow at a CAGR of 4.0% in ...

The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication, Drug Class and Geography

The Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication, Drug Class and Geography
LONDON, UK. 9th June 2017: Visiongain’s new report Global Anti-Inflammatory Therapeutics Market Forecast 2017-2027: Revenue Prospects by Indication (Arthritis, Respiratory, MS, Psoriasis, IBD, Other), Drug Class (Corticosteroids, Anti-Inflammatory Biologics, NSAIDs, Other) and Geography indicates that the Anti-Inflammatory Therapeutics market will see over $75bn in revenue in 2017. The lead analyst of the report said: “The ...

Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates, Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins

Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates, Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins
LONDON, UK May 2017: Visiongain’s new report Global Next-Generation Antibody Therapies Market Forecast 2017-2027: Antibody-Drug Conjugates (ADC), Biosimilar Antibodies, Engineered Antibodies, Bispecific Antibodies, Antibody Fragments and Antibody-Like Proteins (ALPs) indicates that the global next-generation antibody therapies market will see $14.1bn in spending in 2021. The global next-generation antibody therapies market is expected to grow at ...

The Systemic Lupus Erythematosus Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type, Pharmacological Class and Geography

The Systemic Lupus Erythematosus Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type, Pharmacological Class and Geography
LONDON, UK. 8th May 2017: Visiongain’s new report The Systemic Lupus Erythematosus (SLE) Market Forecast 2017-2027: Revenue Prospects by Product, Molecule Type (Small Molecules, mAbs, Recombinant Proteins), Pharmacological Class (B-Cell Targeting, Interferon Receptor Antagonists, CD Antagonists, Other) and Geography indicates that the SLE market will see over $570m in revenue in 2017. The lead analyst ...

Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies

Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies
Translational Regenerative Medicine (TRM) refers to the efforts to ‘translate’ preclinical research on regenerative medicine into clinical therapies – “from bench to bedside”. A great deal of basic research has been performed in the past few decades investigating the therapeutic potential of stem cells, gene replacement and bioengineered tissues. We are now at a point ...